DynPort Medical Countermeasure Development

DynPort is helping the U.S. and allied governments protect soldiers and civilians against emerging diseases and possible bioterror threats.

Programs we've managed include:

U.S. Department of Defense (DoD) Chemical Medical Biological Systems-Joint Vaccine Acquisition Program (CBMS-JVAP)

• Botulinum Bivalent Vaccine
• Plague Vaccine

National Institute of Allergy and Infectious Diseases (NIAID)

• Next-Generation Tularemia Vaccine
• Tularemia (LVS) Vaccine

U.S. Department of Health and Human Services (HHS)

• Influenza Vaccine - Seasonal
• Influenza Vaccine - Pandemic

UK Ministry of Defence

• Scope requirements for licensing plague vaccine in the European Union

Additional Experience

• Anthrax Vaccine (rPA)
• Botulinum Pentavalent Vaccine
• Botulinum Polyclonal Antitoxin
• Botulinum Type E Vaccine
• Butyrylcholinesterase (BioScavenger)
• Smallpox Vaccine (CCSV)
• Vaccine Stockpile, Storage and Maintenance
• Vaccinia Immune Globulin Intravenous (VIGIV)
• Venezuelan Equine Encephalitis Vaccine